JAMA Oncology : Identification of Immune Checkpoint Inhibitor–Induced Diabetes

JAMA Network
29/08/2024 14 min
JAMA Oncology : Identification of Immune Checkpoint Inhibitor–Induced Diabetes

Listen "JAMA Oncology : Identification of Immune Checkpoint Inhibitor–Induced Diabetes"

Descargar episodio Ver en sitio original

Episode Synopsis

Interview with Michelle Rengarajan, MD, PhD, author of Identification of Immune Checkpoint Inhibitor–Induced Diabetes. Hosted by Vivek Subbiah, MD. Related Content: Identification of Immune Checkpoint Inhibitor–Induced Diabetes

More episodes of the podcast JAMA Network

JAMA Otolaryngology–Head & Neck Surgery : Why Hearing Health Must Be Part of Voice Biomarker Research 02/01/2026
JAMA Ophthalmology : Aflibercept Dose in Polypoidal Choroidal Vasculopathy 18/12/2025
JAMA Psychiatry : Tailored Weight Loss Programs for Adults With Serious Mental Illness 17/12/2025
JAMA Surgery : Mortality Among Surgeons in the United States 17/12/2025
JAMA Ophthalmology : The Central Role of Home Hazards in Shaping the Association of Visual Function and Falls in Older Adults 11/12/2025
JAMA Otolaryngology–Head & Neck Surgery : Biofeedback vs Respiratory Retraining for Inducible Laryngeal Obstruction 11/12/2025
JAMA Cardiology : Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement 10/12/2025
JAMA Internal Medicine : Magnesium Supplementation and Tachyarrhythmias 08/12/2025
JAMA Surgery : Diagnosis and Management of Hemodialysis Access Complications 03/12/2025
JAMA Oncology : Metastatic Recurrence Among Adolescents and Young Adults With Cancer 26/11/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA